Wird geladen...
Maintenance of remission with low-dose olopatadine hydrochloride for itch in well-controlled chronic urticaria
BACKGROUND: The long-term follow-up of chronic urticaria (CU) is important to ensure the adequate treatment of patients. Olopatadine hydrochloride is one of the second-generation nonsedating antihistamines. METHODS: This study was designed to assess the optimal dose of olopatadine to suppress sympto...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dove Medical Press
2012
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3459547/ https://ncbi.nlm.nih.gov/pubmed/23055763 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CCID.S36812 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|